Lung-Yi Lee, MD
General Surgery · Honolulu
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Queens University Medical Group · 614 clinicians in this group
Looking this up.
Hospitals listed: The Queens Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Lee’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A147798 · Cancelled
Licence status: Cancelled · since 2017 · University of Pittsburgh School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- The Queens Medical CenterHonolulu, HIAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of The Queens Health Systems, which runs 4 hospitalsPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.34 (1.12 to 1.55), Jul 2022 – Jun 2024Worse than the national rate — Iatrogenic pneumothorax rate: 0.47 (0.29 to 0.65) · 11,638 cases, Jul 2022 – Jun 2024Worse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.32 (3.74 to 6.9) · 3,569 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.79 (1.36 to 2.23) · 10,444 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.453, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.427, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.345, Oct 2024 – Sep 2025
See every measure and the patient survey for The Queens Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 3 better, 3 the same, 2 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.34 (1.12 to 1.55) | Worse | Jul 2022 – Jun 2024 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.47 (0.29 to 0.65) · 11,638 cases | Worse | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.32 (3.74 to 6.9) · 3,569 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.79 (1.36 to 2.23) · 10,444 cases | Worse | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.453 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.427 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.345 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0.12 to 1.78) · 2,583 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.61 (147.16 to 216.07) · 200 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.6 · 101 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 130 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 266 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 619 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.3 · 815 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 1,115 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 7,459 cases | None | Jul 2024 – Jun 2025 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.11 to 0.45) · 12,099 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.17 (0 to 2.44) · 1,411 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.9 (1.73 to 4.06) · 3,175 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.07 (2.95 to 11.2) · 1,400 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.22 (1.54 to 6.91) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.45 (0.06 to 2.83) · 821 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 163 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.751 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.143 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 501 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 1,438 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 10.8 · 272 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -5 · 698 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 15.4 · 799 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 1,657 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.6 (5.1 to 8.6) · 477 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (9.1 to 13.9) · 477 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 171 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.4 · 122 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 17.5 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (10 to 16.1) · 2,546 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 768 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,104 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 52% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$47,755
Medicare paid this office $47,755 for 70 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Transplantation of donor kidney | 16 | $17,925 | $1,120 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $2,672 | $62 |
| New patient visit (45+ min) | 11 | $1,404 | $128 |
Procedures Medicare counted
| Hernia repair - groin (open) | 1-10 | None |
| Hernia repair (minimally invasive) | 1-10 | None |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
70 Original Medicare patients in 2024. Average age 67 · Under 65 39% · Women 36% · Also on Medicaid 16% · Health risk score 6.15. Sicker patients than 9 in 10 peers; the typical general surgery clinician is at 1.69.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 61% · Coronary heart disease 50% · Heart failure 41% · Atrial fibrillation 23% · Cancer 16%.
The office billed $208,993, Medicare allowed $61,049 and paid $47,755; for 231 services of 47 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 70 | 231 | 67 | 6.15 | $208,993 | $47,755 |
| 2023 | 51 | 141 | 65 | 5.48 | $88,554 | $21,237 |
| 2022 | 100 | 283 | 64 | 5.53 | $237,692 | $60,875 |
| 2021 | 87 | 256 | 67 | 5.09 | $155,110 | $45,887 |
| 2020 | 87 | 312 | 67 | 4.80 | $207,980 | $57,502 |
| 2019 | 39 | 98 | 56 | 7.80 | $175,311 | $18,876 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Short return visit | 13 | $973 | $44 |
| Short return visit (20+ min) | 11 | $881 | $73 |
2022: 5 services
| Transplantation of donor kidney | 24 | $27,691 | $1,154 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $4,236 | $51 |
| New patient visit (45+ min) | 24 | $3,150 | $131 |
| Return visit (30+ min) | 22 | $2,776 | $99 |
| Short return visit (20+ min) | 16 | $1,530 | $64 |
2021: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $4,580 | $51 |
| Short return visit (20+ min) | 22 | $2,499 | $66 |
| New patient visit (45+ min) | 12 | $1,735 | $145 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,588 | $113 |
| Return visit (30+ min) | 12 | $1,531 | $102 |
2020: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $6,552 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,118 | $165 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,282 | $107 |
| Short return visit (20+ min) | 15 | $1,266 | $58 |
| Short return visit | 13 | $1,085 | $36 |
2019: 2 services
| Transplantation of donor kidney | 18 | $11,115 | $617 |
| Preparation of donor kidney for transplantation | 11 | $143 | $13 |
Medicaid work
$0 in 2024
Medicaid paid $0 for 46 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Pain severity quantified; no pain present (COA) (ONC) | 15 | $0 |
| Blood pressure has a systolic value of < 140 and a diastolic value of < 90 | 15 | $0 |
| Documentation that patient is a current non-tobacco user | 16 | $0 |
| 2024 | 46 | 3 | 14 | $0 |
| 2023 | 80 | 2 | 15 | $0 |
| 2022 | 200 | 1 | 26 | $689 |
| 2021 | 152 | 1 | 26 | $540 |
See the largest Medicaid services in earlier years
2023
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 15 | $0 |
| Blood pressure has a systolic value of < 140 and a diastolic value of < 90 | 65 | $0 |
2022
| Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease | 200 | $689 |
2021
| Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease | 152 | $540 |
Drugs they prescribed that Part D paid
$9,925
Pharmacies billed $9,925 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 16% of their Part D prescriptions (36 of 224) in 2024. At or below the middle of the specialty; the typical general surgery clinician is at 34%.
215 generic and fewer than 11 brand-name prescriptions · $9,925 in drug cost · 16 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atovaquone | 14 | $2,830 | $202 |
| Valganciclovir | 25 | $2,522 | $101 |
| Prednisone | 11 | $173 | $16 |
| Pantoprazole | 25 | $130 | $5 |
| Atorvastatin | 17 | $112 | $7 |
See all 7 drugs
| Atovaquone | 14 | $2,830 | $202 |
| Valganciclovir | 25 | $2,522 | $101 |
| Prednisone | 11 | $173 | $16 |
| Pantoprazole | 25 | $130 | $5 |
| Atorvastatin | 17 | $112 | $7 |
| Oxycodone | 30 | $81 | $3 |
| Sulfamethoxazole-Trimethoprim | 13 | $77 | $6 |
Year by year
| 2024 | 224 | 42 | 16% (36) | None | $9,925 |
| 2023 | 125 | 44 | 22% (27) | None | $5,937 |
| 2022 | 153 | 35 | 19% (29) | 8% | $15,608 |
| 2021 | 90 | 25 | 12% (11) | None | $5,444 |
| 2020 | 84 | 29 | 17% (14) | None | $7,805 |
| 2019 | 32 | 14 | None | None | $4,405 |
| 2018 | 33 | 27 | 85% (28) | None | $256 |
| 2017 | 37 | 36 | 97% (36) | None | $386 |
| 2016 | 37 | 27 | 62% (23) | 0% | $703 |
| 2015 | 192 | 73 | 37% (70) | 6% | $16,928 |
| 2014 | 19 | 15 | 95% (18) | 0% | $606 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Valganciclovir | 11 | $2,899 | $264 |
| Anastrozole | 12 | $270 | $22 |
| Amoxicillin-Clavulanate Potass | 14 | $215 | $15 |
| Oxycodone | 27 | $100 | $4 |
| Sulfamethoxazole-Trimethoprim | 11 | $72 | $7 |
2022: 4 drugs
| Valganciclovir | 15 | $6,443 | $430 |
| Anastrozole | 11 | $279 | $25 |
| Oxycodone | 27 | $117 | $4 |
| Pantoprazole | 18 | $115 | $6 |
2021: 1 drug
| Amoxicillin-Clavulanate Potass | 12 | $85 | $7 |
2020: 2 drugs
| Valganciclovir | 12 | $3,958 | $330 |
| Oxycodone | 14 | $70 | $5 |
2018: 1 drug
| Hydrocodone-Acetaminophen | 25 | $161 | $6 |
2017: 2 drugs
| Oxycodone | 18 | $247 | $14 |
| Hydrocodone-Acetaminophen | 17 | $124 | $7 |
2016: 2 drugs
| Oxycodone | 17 | $460 | $27 |
| Sulfamethoxazole-Trimethoprim | 11 | $33 | $3 |
2015: 5 drugs
| Oxycodone | 33 | $834 | $25 |
| Clotrimazole | 11 | $542 | $49 |
| Hydrocodone-Acetaminophen | 21 | $199 | $9 |
| Sulfamethoxazole-Trimethoprim | 30 | $171 | $6 |
| Oxycodone-Acetaminophen | 12 | $88 | $7 |
Money from drug and device companies
$365 in 2025
| 2025 | 3 | 5 | None | $365 |
| 2024 | 4 | 8 | None | $539 |
| 2023 | 3 | 4 | None | $124 |
| 2022 | 1 | 1 | None | $115 |
| 2020 | 2 | 2 | None | $66 |
| 2019 | 2 | 2 | None | $275 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sanofi-Aventis U.S. | Thymoglobulin | $262 | 3 payments
|
| Medtronic | Signia | $71 | 1 payment
|
| Veloxis Pharmaceuticals | Envarsus | $32 | 1 payment
|
See all 5 published payments
| Veloxis Pharmaceuticals | Meals · 2025-11-14 | Envarsus | $32 |
| Sanofi-Aventis U.S. | Meals · 2025-10-01 | Thymoglobulin | $112 |
| Sanofi-Aventis U.S. | Meals · 2025-07-21 | Thymoglobulin | $25 |
| Sanofi-Aventis U.S. | Meals · 2025-03-13 | Thymoglobulin | $125 |
| Medtronic | Meals · 2025-01-14 | Signia | $71 |
See earlier years (2024, 2023, 2022, 2020, 2019)
2024: $539
| Sanofi-Aventis U.S. | Thymoglobulin | $243 | 2 payments
|
| FUJIFILM Healthcare Americas | Utaswako Afp-L3 | $205 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Livtencity | $48 | 2 payments
|
| Medtronic | Signia | $43 | 1 payment
|
2023: $124
| Takeda Pharmaceuticals U.S.A. | Livtencity | $70 | 2 payments
|
| Mallinckrodt Hospital Products | Terlivaz | $37 | 1 payment
|
| Ethicon US | Surgicel Nu-Knit | $17 | 1 payment
|
2022: $115
| Takeda Pharmaceuticals U.S.A. | Livtencity | $115 | 1 payment
|
2020: $66
| Davol | Phasix | $52 | 1 payment
|
| Zimmer Biomet Holdings | Surgical-None | $14 | 1 payment
|
2019: $275
| Biom'Up SA | Hemoblast | $144 | 1 payment
|
| Alexion Pharmaceuticals | None | $131 | 1 payment
|
Professional record
- NPI
- 1871819417
- Licence
- CA A147798, WI 56852-20California A147798: Cancelled
- Trained
- University of Pittsburgh School of Medicine, 2010
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Surgery (208600000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2010-04-07
- NPI last updated
- 2019-09-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: Uw Hospital and Clinics, Madison, WI, 53792 · 300 Pasteur Dr, Stanford, CA, 94305